Search Results 921-930 of 19899 for Receptor
The researchers also discovered that a receptor — known as GluR4 — that the NPTX2 protein usually targets in the brain is also found in the kidney cancer ...
Epidermal growth factor receptor (EGFR). EGFR promotes cancer growth. Cetuximab (Erbitux) and panitumumab (Vectibix) target EGFR. These medicines are used ...
Pegvisomant works by binding to the growth hormone receptor and preventing the actions of too much growth hormone . This medicine is available only with ...
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Some people need more aggressive treatment to restore and improve ...
Baudhuin is also working to develop a better understanding of how low-density lipoprotein receptor (LDLR) genetic variants are characterized and associated with ...
Current use or any prior exposure to any calcitonin-gene-related peptide (CGRP) antibody, any antibody to the CGRP receptor, or antibody to nerve growth factor ...
... receptor (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and ...
Dr. Karl-Klaus Conzelmann Dissertation: “Subversion of Toll-like receptor 7/9 signaling by measles virus – V holds the key” Dissertation passed “summa cum ...
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer.
D., is focused on understanding the physiological and pathological functions of apolipoprotein E (APOE) and triggering receptor expressed on myeloid cells 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.